The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology
Open Access
- 1 January 2019
- journal article
- research article
- Published by Medknow in Asian Journal of Andrology
- Vol. 21 (2) , 196-200
Abstract
The clinical predictive factors for malignant testicular histology remain unclear because of the low prevalence. Therefore, the aim of this study was to investigate predictors of malignant histology for testicular masses and decide more testis-sparing surgeries before surgery. This retrospective study enrolled 325 consecutive testicular mass patients who underwent radical orchiectomy (310/325) or testicular preserving surgery (15/325) from January 2001 to June 2016. The clinicopathological factors, including tumor diameter, cryptorchidism history, ultrasound findings, serum alpha-fetoprotein, and human chorionic gonadotropin (HCG) levels, were collected retrospectively for statistical analysis. A predictive nomogram was also generated to evaluate the quantitative probability. Among all patients, 247 (76.0%) were diagnosed with a malignant testicular tumor and 78 (24.0%) with benign histology. Larger tumor diameter (per cm increased, hazard ratio [HR] = 1.284, P = 0.036), lower ultrasound echo (HR = 3.191, P = 0.001), higher ultrasound blood flow (HR = 3.320, P < 0.001), and abnormal blood HCG (HR = 10.550, P < 0.001) were significant predictive factors for malignant disease in all testicular mass patients. The nomogram generated was well calibrated for all predictions of malignant probability, and the accuracy of the model nomogram measured by Harrell's C statistic (C-index) was 0.92. According to our data, the proportion of patients who underwent radical orchiectomy for benign tumors (24.0%) was much larger than generally believed (10.0%). Our results indicated that the diameter, ultrasonic echo, ultrasonic blood flow, and serum HCG levels could predict the malignancy in testicular mass patients.Keywords
This publication has 17 references indexed in Scilit:
- Multiparametric Sonography of Hematologic Malignancies of the Testis: Grayscale, Color Doppler, and Contrast‐Enhanced Ultrasound and Strain Elastographic Appearances With Histologic CorrelationJournal of Ultrasound in Medicine, 2016
- Is contrast-enhanced MRI efficient in testicular infarction mimicking testicular tumor on scrotal ultrasound?Turkish Journal of Emergency Medicine, 2015
- Diagnostic-therapeutic pathway for small lesions of the testisArchivio Italiano di Urologia e Andrologia, 2014
- The predominance of benign histology in small testicular massesUrologic Oncology: Seminars and Original Investigations, 2012
- American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell TumorsJournal of Clinical Oncology, 2010
- High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell TumorsNew England Journal of Medicine, 2007
- Management of Nonpalpable Incidental Testicular MassesJournal of Urology, 2006
- Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilJournal of Clinical Oncology, 2001
- Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.Journal of Clinical Oncology, 1997
- Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.1981